Associations between bronchial hyperresponsiveness and immune cell parameters in patients with chronic fatigue syndrome

Chest

Volumn 123, Issue 4, 2003, Pages 998-1007

  Nijs, Jo ^a   De Becker, Pascale ^a   De Meirleir, Kenny ^a   Demanet, Christian ^a   Vincken, Walter ^a   Schuermans, Daniel ^a   McGregor, Neil ^b  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Bronchial hyperresponsiveness; Chronic; Chronic fatigue syndrome; Immunology; Pathology; Ribonuclease L

Indexed keywords

HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; RIBONUCLEASE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL COUNT; CHRONIC FATIGUE SYNDROME; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME ASSAY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGY; IMMUNOPHENOTYPING; INFLAMMATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MAST CELL; PATHOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROVOCATION TEST; TOTAL LUNG CAPACITY;

EID: 0037387618     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.4.998     Document Type: Article

References (45)

1. De Meirleir K, De Becker P, Campine I, et al. Pulmonary function testing in chronic fatigue syndrome (CFS) [abstract]. Chest 1999; 116(suppl):331S
2. Holmes G, Kaplan J, Gantz J, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108:387-389
3. Klimas NG, Salvato FR, Morgan R, et al. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 98:1403-1410
4. Suhadolnik RJ, Peterson DL, O'Brien K, et al. Biochemical evidence for a novel molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res 1997; 17:377-385
5. Suhadolnik RJ, Reichenbach NL, Hitzges P, et al. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 1994; 18:S96-S104
6. Zhang Q, Zhou X-D, Denny T, et al. Changes in immune parameters seen in gulf war veterans but not in civilians with chronic fatigue syndrome. Clin Diagn Lab Immunol 1999; 6:6-13
7. Levine PH, Whiteside TL, Friberg D, et al. Dysfunction of natural killer cell activity in a family with chronic fatigue syndrome. Clin Immunol Immunopathol 1998; 88:99-104
8. Whiteside TL, Friberg D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 1998; 105:27S-34S
9. Morrison LJ, Behan WH, Behan PO. Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin Exp Immunol 1991; 8:3:441-446
10. De Meirleir K, Bisbal C, Campine I, et al. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med 2000; 108:99-105
11. Fukuda K, Straus S, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121:953-959
12. Goldstein J. How do I diagnose a patient with chronic fatigue syndrome? In: Hyde BM, Goldstein J, Levine P, eds. The clinical and scientific basis of myalgic encephalomyelitis/chronic fatigue syndrome. Ottawa, ON, Canada: The Nightingale Research Foundation, 1992; 247-252
13. European Respiratory Society. Standardized lung function testing: official statement of the European Respiratory Society. Eur Respir J 1993; 16(suppl):1-100
14. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults; report of the Working Party on Standardization of Lung Function Tests, European Community for Steel and Coal - official statement of the European Respiratory Society. Eur Respir J 1993; 16(suppl):53-83
15. Hargreave F, Ryan G, Thomson N. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. Allergy Clin Immunol 1981; 68:347-355
16. Cockcroft DW, Killian DN, Mellon JJA, et al. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7:235-243
17. Steward M, Male D. Immunological techniques. In: Roitt I, Brostoff J, Male D, eds. Immunology. 5th ed. London, UK: Mosby, 1998; 381-395
18. Curry JJ. Comparative action of acetyl-betamethacholine and histamine on respiratory tract in normals, patients with hayfever and subjects with bronchial asthma. J Clin Invest 1947; 26:430-438
19. Ramsdale E, Roberts S, Morris M, et al. Differences in responsiveness to hyperventilation and methacholine in asthma and chronic bronchitis. Thorax 1985; 40:422-426
20. Pang J, Chan H, Sung J. Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis. Thorax 1989; 44:948-951
21. Eggleston P, Rosenstein B, Stackhouse C. Airway hyperreactivity in cystic fibrosis: clinical correlates and possible effects on the course of the disease. Chest 1988; 94:360-365
22. Laitinen L, Kokkola K. Bronchial reactivity to histamine in pulmonary tuberculosis. Scand J Respir Dis 1974; S9:201-205
23. Bechtel J, Start TIII, Dantzker D, et al. Airways hyperreactivity in patients with sarcoidosis. Am Rev Respir Dis 1981; 124:759-761
24. Tiffeneau R, Beauvallet M. Epreuve de bronchoconstriction et de bronchodilation par aerosols. Bull Acad Med 1945; 129:165-168
25. Rook G, Balkwill F. Cell-mediated immune reaction. In: Roitt I, Brostoff J, Male D, eds. Immunology. 5th ed. London, UK: Mosby, 1998; 121-138
26. Martin J, Zeng L, Ahmed K. Cytomegalovirus: related sequence in an atypical cytopathic virus repeatedly isolated from a patient with chronic fatigue syndrome. Am J Pathol 1994; 145:440-451
27. Martin JW. Detection of RNA sequences in cultures of a stealth virus isolated from the cerebrospinal fluid of a health care worker with chronic fatigue syndrome: case report. Pathobiology 1997; 65:57-60
28. Gascon J, Marcos T, Vidal J, et al. Cytomegalovirus and Epstein-Barr virus infection as a cause of chronic fatigue syndrome in travelers to tropical countries. J Travel Med 1995; 2:41-44
29. Okano M, Thiele GM, Purtilo DT. Severe chronic Epstein-Barr virus infection syndrome and adenovirus type-2 infection. Am J Pediatr Hematol Oncol 1990; 12:168-173
30. Nasralla MY, Haier J, Nicolson NL, et al. Examination of mycoplasmas in blood of 565 chronic illness patients by polymerase chain reaction. Int J Med Biol Environ 2000; 28:15-23
31. Vojdani A, Franco AB. Multiplex PCR for the detection of Mycoplasma fermentans, M hominis, and M penetrans in patients with chronic fatigue syndrome, fibromyalgia, rheumatoid arthritis, and Gulf War syndrome. J Chronic Fatigue Syndr 1999; 5:187-197
32. Nicolson GL, Nasralla PY, Franco AR, et al. Role of mycoplasmal infections in fatigue illnesses: chronic fatigue and fibromylagia syndromes, Gulf War illness and rheumatoid arthritis. J Chronic Fatigue Syndr 2000; 6:23-39
33. Kuby J. Hypersensitive reactions. In: Kuby J, ed. Immunology. New York, NY: WH Freeman, 1997; 413-438
34. Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med 1997; 103:38-43
35. Mawle AC, Nisembaum R, Dobbins JG, et al. Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis 1997; 175:136-141
36. Steinberg P, McNutt BE, Marshall P, et al. Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome. J Allergy Clin Immunol 1996; 97:119-126
37. Lloyd AR, Hickie I, Brockman A, et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med 1993; 94:197-203
38. Bazan NG. COX-2 as a multifunctional neuronal modulator. Nat Med 2001; 7:414-415
39. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1 beta-mediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001; 410:471-475
40. Bell IR, Baldwin CM, Schwartz GE. Illness from low levels of environmental chemicals: relevance to chronic fatigue syndrome and fibromyalgia. Am J Med 1998; 105:74S-82S
41. Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997; 4:134-153
42. Buskila D. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 1999; 11:119-126
43. Bennett R. Fibromyalgia, chronic fatigue syndrome, and myofascial pain. Curr Opin Rheumatol 1998; 10:95-103
44. Bakke PS, Baste V, Gulsvik A. Bronchial responsiveness in a Norwegian community. Am Rev Respir Dis 1991; 143:317-322
45. Tashkin DP, Altose MD, Bleecker ER, et al. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. Am Rev Respir Dis 1992; 145:301-310